Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Price Increases Accounted For Over Half Of Drug Spending Growth In 2015

Executive Summary

CMS National Health Expenditures report finds continued double-digit growth rates for retail prescription drug spending in Medicare and Medicaid.

Advertisement

Related Content

Trump Win Is False Security For Drug Makers, Allergan CEO Warns
Part D Reform Proposals From MedPAC May Find Traction After Election
Medicaid Rx Spending Up 24% in 2014 With Expanded Eligibility, HCV Drugs

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS119616

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel